X

Trending Stocks

Electronic Arts (EA)-Glu Mobile (GLUU) acquisition: A move in the right direction

Electronic Arts (NASDAQ: EA) announced on Monday that it is acquiring Glu Mobile Inc. (NASDAQ: GLUU) for an enterprise value…

Gaming turns out to be the highlight of Hasbro’s (HAS) Q4

Shares of Hasbro Inc. (NASDAQ: HAS) were down 4.4% in afternoon hours on Monday, despite the company reporting fourth quarter…

Ford (F) partners with Google for connected vehicles and cloud services

Ford Motor Co. (NYSE: F) announced a new partnership with Alphabet’s (NASDAQ: GOOG) Google unit to accelerate its digital transformation…

Where do these companies stand in the COVID-19 vaccine race?

After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19…

Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals

Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate.…

Novavax (NVAX) brings its share to the COVID-19 vaccine table; stock soars

Novavax Inc.’s (NASDAQ: NVAX) shares soared 50% in morning hours on Friday after the company announced that its COVID-19 vaccine…

$40 to $400 – What’s going on with GameStop’s (GME) stock?

GameStop Corp. (NYSE: GME) is the talk of the town right now. Is it for the right reasons? Can’t tell.…

Beyond Meat (BYND) partnering with PepsiCo (PEP) to make plant-based snacks

Shares of Beyond Meat Inc. (NASDAQ: BYND) soared over 17% in afternoon hours on Tuesday after the company announced a…

Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health

Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth…

Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates

Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical…

What to make of GameStop’s (GME) inexplicable rally

GameStop Corp. (NYSE: GME) is witnessing a rally like none before. Shares surged 35% in morning trade on Monday. The…

Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%

Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab…

General Motors (GM) partners with Microsoft (MSFT) on self-driving vehicles project

Shares of General Motors (NYSE: GM) soared 9% on Tuesday after the company announced a partnership with Microsoft (NASDAQ: MSFT)…

Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch

Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the…

BlackRock, Inc. (BLK) Q4 2020 Earnings Call Transcript

BlackRock, Inc.  (NYSE: BLK) Q4 2020 earnings call dated Jan. 14, 2021 Corporate Participants: Christopher Meade -- Chief Legal Officer Gary Shedlin -- Chief…

Strong digital sales change the face of Target’s (TGT) holiday shopping

Target Corporation (NYSE: TGT) reported double-digit growth in comparable sales during the holiday season. The company saw a massive spike…

Carnival Corporation (CCL): Despite headwinds, there is a positive sentiment around the stock

Without doubt, Carnival Corporation (NYSE: CCL) did not have a good year in 2020. The COVID-19 pandemic halted its operations…

Moderna (MRNA): Development programs, additional approvals provide optimism

Moderna Inc. (NASDAQ: MRNA) seems to be on a roll right now. The stock has skyrocketed over 500% in the…

Tata Motors’ (TTM) stock gains traction amid sales updates and partnership rumors

Shares of Tata Motors Ltd. (NYSE: TTM) were up 4% in morning hours on Tuesday. The stock has been making…

NIO (NIO) generates quite some buzz after a successful NIO Day

NIO Inc. (NYSE: NIO) saw its shares jump 9% on Monday after the company unveiled its new vehicle model along…

Moderna’s (MRNA) stock gains on COVID-19 vaccine approval from the European Commission

Shares of Moderna Inc. (NASDAQ: MRNA) gained 6.3% in afternoon hours on Wednesday as the company received approval from the…